Berweck S - Search Results

1

Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1.

Mainberger F, Jung NH, Zenker M, Wahlländer U, Freudenberg L, Langer S, Berweck S, Winkler T, Straube A, Heinen F, Granström S, Mautner VF, Lidzba K, Mall V. Mainberger F, et al. Among authors: berweck s. BMC Neurol. 2013 Oct 2;13:131. doi: 10.1186/1471-2377-13-131. BMC Neurol. 2013. PMID: 24088225 Free PMC article. Clinical Trial.

2

Psychometric Properties of the German Version of the Rivermead Post-Concussion Symptoms Questionnaire in Adolescents after Traumatic Brain Injury and Their Proxies.

Bockhop F, Zeldovich M, Greving S, Krenz U, Cunitz K, Timmermann D, Bonke EM, Bonfert MV, Koerte IK, Kieslich M, Roediger M, Staebler M, Berweck S, Paul T, Brockmann K, Rojczyk P, Buchheim A, von Steinbuechel N. Bockhop F, et al. Among authors: berweck s. J Clin Med. 2022 Dec 31;12(1):319. doi: 10.3390/jcm12010319. J Clin Med. 2022. PMID: 36615119 Free PMC article.

3

Letter to the Editor Regarding: "Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review" Ann Otol Rhinol Laryngol. 2023 Feb 18; doi: 10.1177/00034894221078365.

Berweck S. Berweck S. Ann Otol Rhinol Laryngol. 2023 Dec;132(12):1696-1697. doi: 10.1177/00034894231176328. Epub 2023 May 26. Ann Otol Rhinol Laryngol. 2023. PMID: 37243317 No abstract available.

4

Management of drooling: 10 years after the Consortium on Drooling 1990.

Berweck S, Schwerin A, Heinen F. Berweck S, et al. Dev Med Child Neurol. 2003 Dec;45(12):845; author reply 845-6. doi: 10.1017/s0012162203221575. Dev Med Child Neurol. 2003. PMID: 14667080 Free article. No abstract available.

5

Sonography-guided injection of botulinum toxin in children with cerebral palsy.

Berweck S, Schroeder AS, Fietzek UM, Heinen F. Berweck S, et al. Lancet. 2004 Jan 17;363(9404):249-50. doi: 10.1016/S0140-6736(03)15351-2. Lancet. 2004. PMID: 14738817 No abstract available.

6

Use of botulinum toxin in pediatric spasticity (cerebral palsy).

Berweck S, Heinen F. Berweck S, et al. Mov Disord. 2004 Mar;19 Suppl 8:S162-7. doi: 10.1002/mds.20088. Mov Disord. 2004. PMID: 15027070 Review.

7

Clinical impact of antibody formation to botulinum toxin A in children.

Herrmann J, Geth K, Mall V, Bigalke H, Schulte Mönting J, Linder M, Kirschner J, Berweck S, Korinthenberg R, Heinen F, Fietzek UM. Herrmann J, et al. Among authors: berweck s. Ann Neurol. 2004 May;55(5):732-5. doi: 10.1002/ana.20098. Ann Neurol. 2004. PMID: 15122715

8

Botulinum toxin B treatment in children with spastic movement disorders: a pilot study.

Schwerin A, Berweck S, Fietzek UM, Heinen F. Schwerin A, et al. Among authors: berweck s. Pediatr Neurol. 2004 Aug;31(2):109-13. doi: 10.1016/j.pediatrneurol.2003.12.016. Pediatr Neurol. 2004. PMID: 15301829

9

[Botulinum toxin--interventional neuropediatrics in spastic movement disorders in childhood].

Berweck S, Heinen F. Berweck S, et al. Kinderkrankenschwester. 2003 Mar;22(3):95-100. Kinderkrankenschwester. 2003. PMID: 15984440 Review. German.

10

Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study.

Mall V, Heinen F, Siebel A, Bertram C, Hafkemeyer U, Wissel J, Berweck S, Haverkamp F, Nass G, Döderlein L, Breitbach-Faller N, Schulte-Mattler W, Korinthenberg R. Mall V, et al. Among authors: berweck s. Dev Med Child Neurol. 2006 Jan;48(1):10-3. doi: 10.1017/S0012162206000041. Dev Med Child Neurol. 2006. PMID: 16359588 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page